Case Report: A Nasopharyngeal Cancer Patient Got COVID-19 During Radiochemotherapy in Wuhan
The coronavirus disease (COVID-19) infection, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Reports of COVID-19 among cancer patients are limited and most studies focus mainly on its epidemiological and clinical features. In this study, we re...
Main Authors: | Weiming Qiu, Fengtao Yi, Xingfeng Ren, Zhaoxia Li, Deqiang Wang, Ning Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.01755/full |
Similar Items
-
Clinical Observation of Concurrent Radio-Chemotherapy Combined with Adjuvant Chemotherapy in Treating Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yan-ping CHEN, Yun-cong LIU, et al.
Published: (2010-02-01) -
Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy
by: Soba Erika, et al.
Published: (2015-12-01) -
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
by: Ran Duan, et al.
Published: (2021-01-01) -
Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT
by: L.H. Braun, et al.
Published: (2020-09-01) -
A cautionary tale of false-negative nasopharyngeal COVID-19 testing
by: Sean S.M. Bullis, et al.
Published: (2020-01-01)